Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review
Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W. Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. Journal of the American Medical Association. 2001 Nov 14;286(18):2270-2279.
Adverse drug reactions are a significant cause of morbidity and mortality. Although many adverse drug reactions are considered nonpreventable, recent developments suggest these reactions may be avoided through individualization of drug therapies based on genetic information, an application known as pharmacogenomics.
|
This item has not yet been rated
|
 |
View article abstract
|
